Chitosan Market

How Big is the Chitosan Market in 2026?

The chitosan market is valued at USD 2.0 billion in 2026 and is projected to reach USD 7.4 billion by 2036, growing at a 13.8% CAGR.

Chitosan market size will reach USD 2.0 Billion in 2026, up from USD 1.8 Billion in 2025, and FMI projects sales of USD 7.4 Billion by 2036 at a 13.8% CAGR. Among adjacent markets, biostimulants market will hold the largest opportunity, adding USD 7.8 Billion at a 10.5% CAGR as growers adopt plant elicitors. The flocculant and coagulant market will add USD 4.8 Billion over 2025 to 2035, with water plants testing bio-based options. The parent chitin market will contribute a smaller USD 1.8 Billion at 6.3%. As per FMI's analysis, chitosan suppliers will find the best ROI in farm and water-treatment grades.

As per FMI's analysis, demand in chitin value chain will move toward converted chitosan grades sold to crop-input, water-treatment, beverage and packaging buyers. Degree of deacetylation, molecular weight and residual protein will decide grade pricing. Regulatory support for farm demand stays intact after the European Commission's July 2025 review kept chitosan approved as a plant elicitor [1].

Key Takeaways of Chitosan Market

• Powder will hold 89.4% of form revenue in 2026 on flexible dosing and cheaper freight.
• Shrimp-derived chitosan will take 56.5% of source revenue in 2026 with steady shell volumes from peeling plants.
• Primex, Heppe Medical Chitosan, Panvo Organics, Tidal Vision, Vietnam Food, Mahtani Chitosan, Golden-Shell Pharmaceutical, and Koyo Chemical are among the key companies operating in chitosan market, out of many players covered in the full report.
• Germany (17.7%) and the UK (17.0%) will post the fastest CAGRs through 2036, and the USA the slowest at 9.8% on established farm and water uses.

Analyst Perspective

"Single-source supply will remain the biggest risk. The 2025 Primex plant fire in Iceland, which halted production for eight months, is a prime example."

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the Chitosan Market Segmented?

The report covers three categories, namely form, source, and region.

Form covers powder and liquid chitosan.
Source covers shrimp, crab, and lobster shells.

Why Does Powder Chitosan Lead the Form Category?

Powder chitosan will hold 89.4% of form market share in 2026

Demand for powder chitosan will remain high. Buyers prefer to set the acid, pH and final strength for each product, from wine clarification tanks to seed-coating lines and supplement capsule plants. Dry grades also cut freight costs, owing to which chitosan powder will keep a wider route to market than liquid grades.

Key challenges for powder suppliers include lot-to-lot variation in viscosity and dissolving speed. Buyers will keep testing each shipment. Japan's Koyo Chemical, for example, lists flake and milled grades by viscosity band, with deacetylation of 75.0% or higher and moisture under 15.0% [2].

• By form, powder chitosan will account for 89.4% market share in 2026.
• Buyers expect tighter powder specifications on every certificate. Koyo Chemical publishes ash limits of 1.0% or less next to deacetylation and moisture specifications for each grade [2].

What Keeps Shrimp as the Leading Source of Chitosan?

Concentrated shell supply from peeling plants will give shrimp-derived material 56.5% market share of source in 2026.

Shrimp shell leads as chitosan feedstock on scale, as peeling plants produce large and regular volumes of shell at one site. Growth of the shrimp market in farmed Asian production keeps that shell stream rising each year. Vietnam Food runs two shrimp co-product plants in Ca Mau and Hau Giang provinces [3]. Primex in Iceland sources shells of North Atlantic coldwater shrimp.[14].

• By source, shrimp-derived material will account for 56.5% of market share in 2026.
• Vietnam Food processes shrimp co-products under ISO 22000, HACCP, GMP, and HALAL systems and exports chitosan to the EU and Asia, turning peeling-plant shell into an export grade [3].

What are the Drivers, Restraints, and Opportunities in the Chitosan Market?

Regulatory acceptance in farming and food processing will drive demand. Grade variation and shellfish allergen rules will slow approvals, and medical and food-contact grades will carry the clearest margin opportunity.

• Driver: Crop-input, water-treatment, and beverage buyers will keep adding chitosan to standard purchase lists as regulators ease approval routes.
• Restraint: Performance shifts with molecular weight, degree of deacetylation, and residual protein, so each new lot or source calls for fresh testing.
• Opportunity: High-purity grades for wound care, pharma excipients, and food-contact paper will command higher prices from buyers needing full traceability.

A steady run of regulatory decisions in farming and food will keep demand for chitosan high. In May 2025, European Commission committee recorded that EFSA found no toxicological concern for approved basic-substance uses of chitosan and chitosan hydrochloride [4]. The Commission's final review report, revised on July 10, 2025, keeps the chitosan approval in current form for cereals, horticulture, grapevines, fruit crops, seed treatment, and post-harvest fruit [1].

Which Country CAGRs are Profiled in the Chitosan Market?

Country	CAGR, 2026 to 2036
Germany	17.7%
UK	17.0%
Japan	14.9%
South Korea	12.1%
USA	9.8%

How do Country-level CAGRs Compare in the Chitosan Market?

As per FMI, profiled country CAGRs span 7.9 percentage points from 2026 to 2036, from Germany at 17.7% to the USA at 9.8%. Germany and the UK sit 0.7 points apart at the top. Japan follows at 14.9%, then South Korea at 12.1%, with the USA last. Food-contact rules, supplement labeling, and the maturity of farm and water use account for most of the gap.

• Germany's 0.7-point lead over the UK comes with a shared need.
• A 2.1-point gap separates the UK from Japan.
• Japan grows 2.8 points faster than South Korea, and suppliers will stock Japanese distributors earlier than Korean ones.
• South Korea stays 2.3 points ahead of the USA, even as Korean supplement makers face periodic MFDS re-evaluation of functional ingredients.

The full FMI report covers country-level CAGRs for 30+ countries across North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa.

Country Outlook

• Sales of chitosan in Germany will grow at a 17.7% CAGR from 2026 to 2036, led by paper mills and food-packaging converters. BfR updates to nine food-contact recommendations took effect on October 1, 2025, and cut allowable bisphenol A migration from recycled paper from 0.05 mg/kg to 0.01 mg/kg [5]. Converters run more migration tests for each new coating, and suppliers with residual-protein data face fewer questions. German buyers shortlist suppliers with analytical labs and deproteinization records, and Halle-based Heppe Medical Chitosan offers local GMP supply [6].
• Allergen data will set the pace of chitosan adoption in UK food packaging. Developers test chitosan films and coatings with that data in hand before retail trials, since residual shellfish protein raises questions for food-contact use. Suppliers sharing deproteinization results and intended-use limits early will shorten the approval cycle with UK food retailers. Demand in the UK will rise at a 17.0% CAGR through 2036.
• Under a notice dated August 25, 2025, the Consumer Affairs Agency removed 31 existing additives with no record of sale from the List of Existing Food Additives, so listed status now tracks active trade [7]. Japanese brewers and supplement makers buy against official specifications. Local suppliers such as Koyo Chemical publish viscosity bands, deacetylation limits, and microbial counts for each grade [2]. The chitosan market in Japan will grow at a 14.9% CAGR over the forecast period.
• Health-functional-food makers will shape chitosan adoption in South Korea, with growth at a 12.1% CAGR till 2036. MFDS runs periodic safety and efficacy re-evaluations of functional ingredients, and in September 2026 named ten ingredients for 2027 review with a December 31, 2026 deadline for company data [8]. Korean brands therefore need matching safety files from raw-material suppliers. FMI expects these review cycles to add compliance cost for smaller supplement brands, keeping South Korea below Japan.
• Established farm and water uses give the USA a large base, so a 9.8% CAGR from 2026 to 2036, the slowest among profiled countries, still builds on sizeable volume. Bellingham-based Tidal Vision sells Tidal Clear water-treatment and Tidal Grow agriculture products from one production facility [9]. A March 2026 USDA technical report on fungal chitosan in organic winemaking shows crustacean suppliers now facing a non-shellfish rival in some food uses [10].

Who are the Notable Companies in the Chitosan Market?

Key companies profiled by FMI include Primex, Heppe Medical Chitosan, Panvo Organics, Tidal Vision, Vietnam Food, Mahtani Chitosan, Golden-Shell Pharmaceutical, and Koyo Chemical.

Chitosan market share among suppliers follows shell traceability, grade documentation, and hands-on application support. FMI groups the profiled companies into three strategy cohorts. Fungal chitosan producers such as KitoZyme are discussed as competitive pressure but not scored, since fungal material falls outside the crustacean source segmentation. Buyers will compare suppliers on certificates of analysis, source records, and the speed of technical help during trials.

• Medical and Pharma Grade Specialists: Primex, Heppe Medical Chitosan, and Panvo Organics sell into regulated uses with GMP or medical-device quality systems.
• Shell By-product Integrators for Industrial Uses: Tidal Vision, Vietnam Food, and Mahtani Chitosan convert seafood waste into chitosan for water treatment, farming, and materials.
• Export-focused Asian Food and Nutraceutical Suppliers: Golden-Shell Pharmaceutical and Koyo Chemical sell specified food and supplement grades to overseas and domestic brand owners.

Competitive Benchmarking

Company	Feedstock Traceability	Grade Characterization	Application Support	Geographic Reach
Primex	High	High	High	Global, through a network of distributors and warehouses
Heppe Medical Chitosan	Medium	High	High	Europe, with international medical and research customers
Panvo Organics	Low	Medium	Medium	India, with exports to regulated markets
Tidal Vision	Medium	Medium	High	North America, expanding into Europe
Vietnam Food	High	Medium	Medium	Southeast Asia, with exports to the EU and Asia
Mahtani Chitosan	Medium	Low	Medium	India
Golden-Shell Pharmaceutical	Medium	High	Medium	China, exporting to over 30 countries, with a U.S. subsidiary
Koyo Chemical	Medium	High	Medium	Japan, sourcing across East and Southeast Asia

Scoring basis: Feedstock Traceability measures documented control over crustacean species, shell origin, and supply chain. Grade Characterization measures published specifications for degree of deacetylation, viscosity or molecular weight, purity, and quality certification. Application Support measures documented formulation help, product lines, or technical services for end uses. High indicates broad, clearly documented capability, Medium indicates credible but narrower documented capability, and Low indicates limited public documentation for the criterion. Geographic Reach reflects evidenced sales, distribution, export, or facility activity. Each score rests on public company documentation reviewed by FMI in September 2026.

Key Developments

• In March 2026, USDA's Agricultural Marketing Service released a technical report on an Enartis USA petition seeking approval of fungal chitosan in organic winemaking [10].
• In July 2025, the European Commission revised the final review report for basic substance chitosan, keeping the approval in current form [1].

Key Players

Medical and Pharma Grade Specialists

• Primex
• Heppe Medical Chitosan
• Panvo Organics

Shell By-product Integrators for Industrial Uses

• Tidal Vision
• Vietnam Food
• Mahtani Chitosan

Export-focused Asian Food and Nutraceutical Suppliers

• Golden-Shell Pharmaceutical
• Koyo Chemical

Report Scope and Methodology

Coverage field	Report scope
Market breakdown	3 categories: Form (Powder, Liquid), Source (Shrimp, Crab, Lobster), and Region
Quantitative units	USD Billion
Market definition	Revenue from sales of powder and liquid chitosan derived from shrimp, crab, or lobster feedstocks within the stated Form and Source segmentation. The market excludes downstream finished-product revenue, chitin, separately sold chitosan derivatives, and substitute biopolymers.
Regions covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	30+ countries, including the USA, UK, Germany, Japan, and South Korea
Key companies profiled	A few of the notable companies out of many players covered by FMI include Primex, Heppe Medical Chitosan, Panvo Organics, Tidal Vision, Vietnam Food, Mahtani Chitosan, Golden-Shell Pharmaceutical, and Koyo Chemical
Forecast period	2026 to 2036
Approach	FMI applies a hybrid bottom-up and top-down sizing framework that reconciles shell feedstock availability, chitosan output and supplier revenue with grade pricing and demand-side signals from farming, water treatment, food, supplement and medical buyers.

Research Methodology

Method	Approach
Primary research	FMI's primary-research framework engages chitosan producers, shrimp and crab processors, distributors, crop-input and water-treatment formulators, beverage and supplement buyers, and quality specialists to test grade requirements, source preferences, pricing and approval timelines.
Desk research	The analysis reviews regulator publications on pesticides, food additives, food-contact materials and health-functional foods, along with clinical literature, company announcements and technical data sheets. FMI retains sources that define buying mechanisms, supplier roles or country conditions inside the market boundary.
Market sizing and forecasting	The sizing framework links shell volumes from seafood processing and chitin conversion yields with powder and liquid grade pricing and end-use demand. Forecasts consider regulatory changes, capacity additions, plant outages and competition from fungal chitosan.
Data validation	Supplier evidence is checked against demand-side indicators, and segment logic is tested against the revenue boundary. Chitin revenue, derivative revenue, finished products and substitute biopolymers are excluded before final reconciliation to prevent double counting.

Chitosan Market by Segments

Chitosan Market Segmented by Form

• Powder
• Liquid

Chitosan Market Segmented by Source

• Shrimp
• Crab
• Lobster

Chitosan Market Segmented by Region

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• [1] European Commission (2025, July 10). Final Review report for the basic substance chitosan, SANTE/10594/2021 Rev. 4.
• [2] Koyo Chemical (2026, September). KOYO Chitosan.
• [3] Vietnam Food (2026, September). Products, BioPolymers, Chitosan.
• [4] European Commission (2025, May 14-15). Summary Report: Standing Committee on Plants, Animals, Food and Feed, Section Phytopharmaceuticals, Legislation.
• [5] Pack-Lab (2025, November 17). BfR Strengthens Standards for Paper FCMs.
• [6] Heppe Medical Chitosan (2026, September). Chitosan, products and services.
• [7] ChemLinked (2025, August 29). Updated: Japan's Regulatory Changes for Food Additives in 2025.
• [8] NutraIngredients (2026, September 11). Regulatory review: Ingredients safety re-evaluation, NMN product naming and more.
• [9] Tidal Vision (2026, September). Tidal Vision, Your Chitosan Solutions Manufacturer.
• [10] USDA Agricultural Marketing Service (2026, March 5). Chitosan Handling/Processing Technical Report.
• [11] RÚV (2026, July 10). Primex restarts production after major fire last year.
• [12] Panvo Organics (2026, September). About Us.
• [13] Golden-Shell Pharmaceutical (2026, September). About Us.
• [14][ Primex ehf (2026, September). Quality & Environment.

This bibliography is provided for reader reference and is not exhaustive. Company web pages were accessed in September 2026. The full FMI report contains the complete reference list and detailed citations.

This Report Answers

• What will the Chitosan Market size be in 2026, and what value will the market reach by 2036?
• Which regulatory decisions and processing needs will support demand for chitosan in farming, water treatment and beverages?
• Why will Powder hold the leading position within the Form category in 2026?
• How will Shrimp shell supply shape chitosan costs, allergen testing and source qualification?
• How will growth rates differ across Germany, the UK, Japan, South Korea, and the USA till 2036?
• How will buyers assess the roles and capabilities of the profiled chitosan suppliers?
• How will grade variation and residual shellfish protein slow supplier approval?
• What effect will fungal chitosan have on crustacean chitosan in food and wine uses?
• What will procurement and formulation teams need to check before approving a chitosan grade?